Kinoshita Fukuaki Lee, Ito Yuri, Morishima Toshitaka, Miyashiro Isao, Nakayama Tomio
School of Medicine, Osaka University.
Japan Community Health care Organization Osaka Hospital.
Jpn J Clin Oncol. 2017 Sep 1;47(9):863-869. doi: 10.1093/jjco/hyx094.
Several studies of sex differences in lung cancer survival have been reported. However, large-size population-based studies based on long-term observation are scarce. We investigated long-term trends in sex differences in lung cancer survival using population-based cancer registry data from Osaka, Japan.
We analyzed 79 330 cases from the Osaka Cancer Registry (OCR) diagnosed between 1975 and 2007. We calculated 5-year relative survival in the six periods (1975-1980, 1981-1986, 1987-1992, 1993-1997, 1998-2002 and 2003-2007). To estimate the trends in sex differences in lung cancer survival throughout the study period, we applied a multivariate excess hazard model to control for confounders.
The proportion of adenocarcinoma (ADC) and 5-year relative relative survival have increased for both sexes. Sex differences in lung cancer survival have widened over the period, especially in ADC and since the late 1990s. The excess hazard ratio of death within 5 years for males was 1.19 (95% CI: 1.16-1.21), adjusting for period at diagnosis, histologic type, stage, age group and treatment.
We reported that females have better prognosis in lung cancer than males and the sex differences in lung cancer survival have become wider in Osaka, Japan. This can be partly explained by the sex differences in the proportions of histologic type and stage. Further studies considering other factors that influence sex differences in lung cancer survival are needed.
已有多项关于肺癌生存率性别差异的研究报道。然而,基于长期观察的大规模人群研究却很匮乏。我们利用日本大阪的人群癌症登记数据,调查了肺癌生存率性别差异的长期趋势。
我们分析了大阪癌症登记处(OCR)在1975年至2007年间诊断的79330例病例。我们计算了六个时期(1975 - 1980年、1981 - 1986年、1987 - 1992年、1993 - 1997年、1998 - 2002年和2003 - 2007年)的5年相对生存率。为了估计整个研究期间肺癌生存率性别差异的趋势,我们应用多变量超额风险模型来控制混杂因素。
腺癌(ADC)的比例和两性的5年相对生存率均有所上升。在此期间,肺癌生存率的性别差异有所扩大,尤其是在腺癌方面,且自20世纪90年代末以来一直如此。在调整了诊断时期、组织学类型、分期、年龄组和治疗等因素后,男性5年内死亡的超额风险比为1.19(95%置信区间:1.16 - 1.21)。
我们报告称,在日本大阪,女性肺癌患者的预后比男性更好,且肺癌生存率的性别差异变得更大。这可以部分地通过组织学类型和分期比例的性别差异来解释。需要进一步研究考虑其他影响肺癌生存率性别差异的因素。